Onco - Lung ppt Flashcards

1
Q

true about lung cancer EXCEPT

a. lung cancer is most common cause of cancer death
b. lung cancer is common in young adults, above 20 years
c. the projected lifetime probability of developing lung cancer is 8% among males, and 6% among females
d. NOTA

A

B; uncommon below age 40, rates increase until age 80; rate tapers off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Projected lifetime probability of developing lung cancer is estimated to be __ among males, and ___ among females

A

8% and 6% respectively

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

cigarette smokes have increased risk of developing lung cancer compared to those who have never smoked by how much?

A

10-fold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

one genetic mutation is induced per this number of cigarettes smoked?

A

15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Former smokers have an increased risk of developing lunch cancer compared to never smokers?

A

nine-fold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

the following statement/s are true

a. Smoking cessation does not reduce the risk of developing lung cancer compared to current smokers
b. Smoking cessation reduce the risk of cancer compared to those who don’t quit and the size of risk reduction is independent with the length of time the person has quit smoking
c. Environmental tobacco smoke and second hand smoking have the same risk of developing lung cancer as active smokers.
d. Exposure to asbestos, aresenic, bischloromethyl ether, hexavalent chromium, mustard gas, nickel and polycyclic aromatic carbons can cause lung cancer.

A

D
a and b. smoking cessation reduce the risk of developing lung CA and the longer a person has quit, the greater the risk reduction is.
c. Environmental tobacco smoke and second hand smoking has less risk for developing lung CA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Certain genetic polymorphisms of the ____ enzyme system, specifically ____ and chromosome fragility are associated with the development of lung cancer

A

P450

CYP1A1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

First degree relatives of lung cancer probands have a __ to ___ fold excess risk of lung cancer and other cancers, many of which are not smoking related

A

two to three

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

inherited mutations in these genes may develop lung cancer

A

RB

p53

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Rare germline mutation involvng epidermal growth receptor linked to lung cancer susceptibility in never smokers

A

T790M

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A susceptibility locus on this chromosome greatly increases risk of lung cancer among light and never smokers

A

chromosome6q

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

4 major cell types of lung cancers (WHO classification)

A

small cell lung cancer
adenocarcinoma
squamous cell carcinoma
large cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

cancer cell type related to heavy tobacco use

l

A

small cell lung CA

squamous cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

packyears to be considered light smoker

A

<10pack-year history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

most common cell type of lung cancer in <10packyear hx, women, <60y.o.

A

adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

the following statements are true EXCEPT

a. the distinction between squamous and nonsquamous lung cancer is not critical to optimal therapeutic decision
b. daiagnosis of non-small cell carcinoma not otherwise sepcified is no longer considered acceptable
c. TTF-1 or Napsin A are adenocarcinoma immunohistochemistry marker
d. p40 or p63 are squamous markers

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Four categories for classifying predominant pattern of lung cancer

A

lepidic predominant
acinar and papillary
solid-predominant
micropapillary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

adenocarcinoma markers

a. p40
b. p53
c. p63
d. TTF-1

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

adenocarcinoma markers

a. p40
b. p53
c. RB
d. napsin-A

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

give 2 sqamous markers

A

p40 and p63

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

favorable prognosis

a. lepidic
b. acinar
c. papillary
d. solid-predominant
e. micropapillary

(if answer is more than one, give both letters)

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

poor prognosis

a. lepidic
b. acinar
c. papillary
d. solid-predominant
e. micropapillary

(if answer is more than one, give both letters)

A

D and E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q
intermediate prognosis
favorable prognosis
a. lepidic
b. acinar
c. papillary
d. solid-predominant
e. micropapillary

(if answer is more than one, give both letters)

A

B and C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

types of squamous cell carcinoma (3)

A

keratinizing
nonkeratinizing
basaloid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

markers to verify neuroendocrine differentiation within a tumor (6)

A
neuron specific enolase (NSE)
CD56
NCAM
Synaptophysin
chromogranin
Leu7
26
Q

________ is identified in tumors of thyroid and pulmonary origin, is positive in over 70% of pulmonary adenocarcinomas and is a reliable indicator of primary lung cancer, provided a thyroid primary has been excluded.

A

TTF-1

27
Q

______ is an aspartic protease that plays an important role in maturation of surfactant B7 and is expressed in cytoplam of type II pneumocytes

A

Napsin-A

28
Q

Nap A positive, TTF-1 positive

a. primary lung adenocarcinoma
b. primary lung squamous cell carcinoma
c. primary SCLC

A

A

29
Q

Nap A negative TTF-1 positive

a. primary lung adenocarcinoma
b. primary lung squamous cell carcinoma
c. primary SCLC

A

C

30
Q

Nap A negative TTF-1 negative

a. primary lung adenocarcinoma
b. primary lung squamous cell carcinoma
c. primary SCLC

A

B

31
Q

CK7 negative CK20 negative

a. nonsquamous NSCLC
b. SCLC
c. mesothelioma
d. squamous cell ca

A

D; the others are CK7 positive, CK20 negative

32
Q

useful marker for detection of NSCLCs with sqamous differentiation when used in cytologic pulmonary samples

a. p63
b. ROS1
c. KRAS
d. ALK

A

A

33
Q

Several markers in the last few years have proven to be more helpful including ____, _____, _____, ` all of which show positivity in mesothelioma.

A

CK5/6
calretinin
Wilms tumor gene-1

34
Q

True of MYC

a. one of the earliest sets of oncogenes found to be aberrant
b. most frequently activated via gene point mutation or transcriptional dysregulation in both SCLC and NSCLC
c. Nearly 90% of SCLC harbor mutations in TP63 and RB1
d. AOTA

A

A

b. amplification instead of point mutation; TP53 instead of TP63

35
Q

Most common driver mutations in lung carcinoma

A

KRAS, but most cases are unkown

36
Q

True about early detection and screening EXCEPT

a. in lung cancer, clinical outcome is related to the stage at diagnosis
b. low dose non contrast, thin slice spiral chest CT has emerged as an effective tool to screen for lung cancer.
c. a patient 45 year old, with history of 25 packyear history of cigarette smoking is a high risk patient
d. former smokers must have quit within the previous 15 years

A

C; high risk individuals: between 55-74 years, >=30 packyear hx

37
Q

Describe the prototypical lung CA patient

A

current or former smoker, either sex, usually in the 7th decade of life

38
Q

Patient with chronic cough, without hemoptysis, 10 packyears, quit 15 years ago, 60 y.o. with COPD, the ff statements are true

a. should prompt a thorough investigation for lung cancer
b. if CXR is normal, no further tests needed
c. both
d. neither

A

A; hx of chronic cough with or without hemoptysis in a current or former smoker with COPD age 40 years or older should prompt a thorough investigation for lung cancer even in the face of a normal CXR

39
Q

A persistent pneumonia without constitutional symptoms merits a thorouguh investigation for underlying course if…

A

unresponsive to repeated courses of antibiotics

40
Q

lung cancer arising in a lifetime never smoker is more common in ____ and ____

A

women and East Asians, younger than their smoking counterparts

41
Q

_______ is required to confirm a diagnosis in all patients with suspected lung cancer

A

Tissue sampling

42
Q

Given greater emphasis placed on molecular testing for NSCLC patients, a ______ is preferred to ensure adequate tissue for analysis

A

core biopsy

43
Q

Tumor tissue maybe obtained via minimally invasive techniques such as (6)

A
bronchial biopsy
transbronchial biopsy
fiberoptic bronchoscopy
FNA
percutaneous biopsy
EBUS guided biopsy
44
Q

biopsy is done in patients with

A

clinically palpable disease such as lymph node or skin metastasis

45
Q

Percutaneous biopsy is done in patients with suspected metastatic disease. Samples can be taken from

A
soft tissue mass
lytic bone lesion
bone marrow
pleural lesion
liver lesion
adequate cell block obtained from a malignant pleural effusion
46
Q

True of lung cancer staging except

a. lung cancer staging includes determination of location of tumor and metastatic sites and assessment of a patient’s ability to withstand various antitumor treatments
b. most significant dividing line is between those patients who are candidates for surgical resection and those who are inoperable but will benefit from chemotherapy, radiation therapy, or both.
c. both
d. neither

A

C

47
Q

give 4 contraindications ot potential curative resection in NSCLC

A

extrathoracic metastases
superior vena cava syndrome
vocal cord and, in most cases, phrenic nerve paralysis
malignant pleural effusion
cardiac tamponade
tumor within 2 cm of the carina
metastases to the contralateral lung
metastases to supraclavicular lymph nodes
contralateral mediastinal node metastases
involvement of the main pulmonary artery

48
Q

1s FEV1 of greater than __ L or greater than ___% of predicted can tolerate a pneumonectomy

A

2L

80%

49
Q

FEV1 greater than ___ L have adequate reserve for lobectomy

A

1.5L

50
Q

VO2 max of ___ mL/kg. min predicts for a higher risk of postoperative complications

A

<15

51
Q

in patients with myocardial infarction within the past 3 months is a contraindication to thoracic surgery. What percent of patients will die of reinfarction?

A

20%

52
Q

major contraindications for surgery include the ff EXCEPT

a. uncontrolled arrhythmia
b. FEV1 of less than 1L
c. Co2 retention
d. severe pulmonary hypertension
e. resting PCO2 >35mmHg
f. DLCO <40%

A

E; >45mmHg

53
Q

true for treatment of lung cancer metastatic disease

a. platinum based chemotherapy for maintenance
b. premetrexed for squamous
c. gemcitabine for nonsquamous
d. AOTA
e. NOTA

A

A
gemcitabine for squamous
premetrexed for nonsquamous

54
Q

True of targeted therapy EXCEPT

a. EGFR mutations have been detected in 10-20% of NOrth American patients diagnosed with NSCLC
b. EGFR mutations are associated with younger age
c. EGFR mutations associatied with <10 pack year and nonsmokers
d. EGFR mutations associated with adenocarcinoma

A

A; 10-15%

55
Q

Exon deletions associated with EGFR

A

exon 21
exon 19
L8583

56
Q

FDA approved oral small molecule TKIs that inhibit EGFR

A

erlotinib
gefitinib
afatinib

57
Q

Disease progression occurs usually around how many months?

A

12months

58
Q

Approximately what percentage of patients harbor a second site mutation?

A

50%

59
Q

T790M mutation occur within exon ___

A

exon 20

60
Q

Third gen mutant selective EGFR TKI specific for T790M

A

Osimertinib

61
Q

Similar to EGFR, ___ rearrangements are typically but not exclusively associated with younger age, light <10packyear and nonsmokers, and adenocarcinoma histology

A

ALK